Enhanced Investments - Financial Portal

Oliver Wyman Gathers Senior Healthcare Executives for Annual Health Innovation Summit

Published: 2023-09-14 17:04:00 ET

AI, emergence of new drugs and the future of aging are topics for the 11th annual event

CHICAGO--(BUSINESS WIRE)-- Adoption of generative AI and the emergence of new weight-loss drugs are two of the breakthrough trends that leaders from across healthcare will examine during this year’s Oliver Wyman Health Innovation Summit. They’ll also explore the role of pharmacy benefit managers, the future of hospitals as care moves to other sites, and lessons learned from 10 years of the Affordable Care Act. Oliver Wyman is a global management consulting firm and a business of Marsh McLennan (NYSE: MMC).

The invitation-only event, September 18-20 in Chicago, brings together more than 350 senior healthcare leaders from 200 companies committed to transforming healthcare in the pursuit of a better way. The theme of this year’s event is Doing What Matters: The Paths to Progress.

“It’s an exciting time in healthcare and in healthcare innovation,” said Sam Glick, partner and global leader of Oliver Wyman’s Health and Life Sciences practice. “We are seeing new technologies and therapeutics come to market at a rapid pace. Innovation — whether by incumbents or start-ups — is forcing us to rethink business, payment, and clinical care models. At the same time, we must pay attention to the fundamentals. We can’t try to force an innovation on top of a broken or flawed infrastructure. And, critically, there isn’t a one-size-fits all approach. This year’s theme — the paths to progress — highlights the need for us to be flexible and take into account the differences that exist across markets, segments of the industry, and communities.”

This year’s Summit includes insights from some of the industry’s most influential executives and thought leaders, including:

Joe DeRisi, PhD, President, Chan Zuckerberg Biohub SF and Professor of Biochemistry and Biophysics, University of California, San Francisco
Scott Frisch, Executive Vice President and Chief Operating Officer, AARP
Camille Harrison, Executive Vice President, Medicare and Chief Innovation and Experience Officer, GuideWell
Sachin Jain, MD, CEO SCAN Group and SCAN Health Plan
Lina Khan, Chair, US Federal Trade Commission
Tanvi Patel, Director, Amazon Pharmacy

In our immersive and experiential exhibit, Into the ElderVerse, attendees will feel the realities of aging and explore how we make getting older a dignified, rewarding experience for all.

We’ll also hear fromPeter Sagal, the longtime host of one of NPR’s most popular and Peabody Award-winning shows, Wait, Wait…Don’t Tell Me! and author of The Incomplete Book of Running and The Book of Vice: Very Naughty Things (and How to Do Them).

The MedCity News Insights Lounge will interview speakers and attendees live from the Summit about their strategies and views for the future of healthcare.

Executive Sessions will cover topics such as:

Care Delivery Dominoes: What Happens When We Don’t Need All Our Buildings Anymore?
Makeover Or Reinvention: What’s The Prescription for PBMs?
Not An Oxymoron: High-Performing Medical Groups
Paging Doctor AI: How “Human” Will Healthcare Delivery Be in 2035?
Insuring The ElderVerse: The Next Generation of Medicare Advantage

The Oliver Wyman Health Innovation Summit would not be possible without the generous support of our partners: Gold partners Carrot Fertility and Surround Care; Silver partners Emcara, Motive Practicing Wisely Solutions, and TytoCare; Innovator partners Amitech, Flume, TruLite Health, and Vida.

Individuals not attending the event can access real-time insights and perspectives through Oliver Wyman’s social media channels, including Twitter via @OliverWyman, @OWHealthEditor and LinkedIn via Oliver Wyman and Oliver Wyman Health. All content can be found following #OWHIC. Exclusive real-time content will also be available on digital publication, Oliver Wyman Health. Executive interviews will be hosted in the MedCity News Insights Lounge and shared via Oliver Wyman’s YouTube channel.

For more information on this year’s event or to speak with Oliver Wyman about the Summit, please contact Francine Minadeo at francine.minadeo@oliverwyman.com. For a complete agenda and roster of speakers, please visit the event website.

About Oliver Wyman

Oliver Wyman is a global leader in management consulting. With offices in more than 70 cities across 30 countries, Oliver Wyman combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. The firm has more than 6,000 professionals around the world who work with clients to optimize their business, improve their operations and risk profile, and accelerate their organizational performance to seize the most attractive opportunities. Oliver Wyman is a business of Marsh McLennan [NYSE: MMC].

About Oliver Wyman Health Innovation Center

Oliver Wyman launched the Health Innovation Center (OWHIC) in 2011 to accelerate health market transformation. OWHIC champions innovation by disseminating proven innovations; envisioning market-based solutions to today’s and tomorrow’s challenges; and establishing a cross-industry community of thought-leaders to share and shape ideas.

For the latest on the business of transforming healthcare, visit the Oliver Wyman Health digital platform at health.oliverwyman.com and follow us on Twitter @OWHealthEditor. For more information, visit oliverwyman.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230914988789/en/

Francine Minadeo E: francine.minadeo@oliverwyman.com T: 917-573-8826 Follow us on Twitter @OliverWyman

Source: Oliver Wyman

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.